Clinical Trial Update: Effects of Intravenous GSK3858279 on a Battery of Evoked Pain Tests in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intravenous GSK3858279 effects on evoked pain tests in healthy volunteers; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• GSK3858279

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pain | Phase 1 | Status: TERMINATED | Results posted: 2023-08-01